Apr 11, 2002
1:300
For every 300 shares held, investors received 1. The price per share adjusted from $0.01 to $0.00.
The split itself did not change the total investment value.
Provectus Biopharmaceuticals, Inc. (PVCT) trades on the Other OTC in the Biotechnology industry.
Provectus Biopharmaceuticals, Inc. company overviewThe latest split shown was on April 11, 2002. It was a 1-for-300 reverse split, so shareholders received 1 share for every 300 they held.
This history records 2 reverse splits between June 28, 2000 and April 11, 2002.